Nema internetske veze — prikazuje se spremljena verzija stranice.

Novo Nordisk A/S

DEEUR
← Na Filtar Dionica

Novo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 3. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

⚠ Nemojte brkati: postoji još jedna tvrtka s istim ili vrlo sličnim imenom. Ovo je zaseban zapis — provjerite ticker, burzu i registracijski broj.

O Tvrtki

Web-Stranica
novonordisk.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
BAGSVAERD DENMARK, Denmark
Glavni Direktor
Maziar Mike Doustdar
Zaposlenici
66 700
Dionice u Optjecaju
3.34 mlrd.
Slobodno Prenosive Dionice
3.17 mlrd.
Tržišna Kapitalizacija
150.93 mlrd. EUR
Insajderi
5.27%
Institucionalni Ulagači
33.78%
Djelatnost (SIC)
Pharmaceutical Preparations
Pravni Oblik
ZRPO
ISIN
DK0060534915
LEI
549300DAQ1CVT6CXN342
Omjer Isplate
50.5%
FCF
59.0 mlrd. DKK
Isplata / FCF
88%
Dug
143 mlrd. DKK
2.0 g. FCF
Dividendni Staž
24 g.
Zarada, FCF i isplaćene dividende — za 12 mjeseci do 31.12.2025 (najnovije izvješće tvrtke).
Opis

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
XETRA XetraNOV glavnaEUR33.21 +0.00%obične dionice
LSE London Stock Exchange0QIU IOBGBP257.55 +1.45%obične dionice
US USA StocksNONOF OTCUSD38.84 -1.61%obične dionice

Cijena za 3 Mjeseca

dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Godišnje, US:NONOF: 11.7 DKK (2 ispl.)

Novo Nordisk A/S (NONOF) isplaćuje dividende dvaput godišnje. Godišnje (12 mjeseci do uključivo posljednje najavljene isplate): 11.7 DKK po dionici (isplata: 2). Prema povijesti isplata, sljedeći datum ex-dividende očekuje se oko 15.02.2027. Godine neprekinutih dividendi: 24.

Ex-DatumIsplataIznos%VrstaOznaka
2026-08-172026-08-183.7500 DKK1.2/3.9 %polugodišnjiUS:NONOF
2026-03-302026-03-317.9500 DKK3.4/5.0 %polugodišnjiUS:NONOF
2025-08-182025-08-193.7500 DKK1.1/3.4 %polugodišnjiUS:NONOF
2025-03-312025-04-017.9000 DKK1.7/2.5 %polugodišnjiUS:NONOF
2024-08-162024-08-193.5000 DKK1.4/3.8 %polugodišnjiUS:NONOF
2024-03-222024-03-266.4000 DKK2.5/≈4.9 %polugodišnjiUS:NONOF

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
VANGUARD STAR FUNDS-Vang…1.38%46.88 mil.2026-07-31
EuroPacific Growth Fund-…1.07%36.2 mil.2026-06-30
VANGUARD TAX-MANAGED FUN…0.92%31.13 mil.2026-06-30
Capital World Growth & I…0.77%26.02 mil.2026-06-30
iShares Trust-iShares Co…0.71%24.13 mil.2026-08-31
Income Fund of America0.52%17.78 mil.2026-07-31
Dodge & Cox Funds-Dodge…0.39%13.1 mil.2026-06-30
Fidelity Concord Street…0.37%12.52 mil.2026-07-31
iShares Trust-iShares MS…0.34%11.48 mil.2026-08-31
Capital Income Builder0.3%10.32 mil.2026-07-31
Cygnus Capital Advisors,…0%78 8002026-06-30
Generali Investments Cee…0%27 3992026-06-30
Pacer Advisors, Inc.0%24 4102026-06-30
Atlas Capital Advisors I…0%5 2182026-06-30
Novo Holdings———
Novo Nordisk Foundation———